1. Bioanalytical Method Validation Guidance for Industry | FDA [WWW Document], n.d. URL https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioanalytical-method-validation-guidance-industry (accessed 8.14.23).
2. Botanical Drug Development: Guidance for Industry | FDA [WWW Document], n.d. URL https://www.fda.gov/regulatory-information/search-fda-guidance-documents/botanical-drug-development-guidance-industry (accessed 8.14.23).
3. Center for Drug Evaluation and Research, (2005) Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. US Department of Health and Human Services.
4. Cho HY, Choi GW, Lee YB (2019) Interpretation of Non-clinical data for prediction of human pharmacokinetic parameters: In vitro-in vivo extrapolation and allometric scaling. Pharmaceutics 11(4):168. https://doi.org/10.3390/PHARMACEUTICS11040168
5. Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers | FDA [WWW Document], n.d. URL https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers (accessed 8.14.23).